ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
Provided By GlobeNewswire
Last update: Nov 14, 2024
FREMONT, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, is pleased to announce its financial results and key operational highlights for the third quarter ended September 30, 2024.
Read more at globenewswire.com0.6996
+0.11 (+19.59%)
Find more stocks in the Stock Screener
ABVC Latest News and Analysis
2 days ago - ChartmillOn Friday, there are stocks with unusual volume. Let's take a look.The trading volume of these stocks is deviating from the norm in today's session.
